Literature DB >> 8488807

Unrecognized pertussis infection in adolescents.

B A Cromer1, J Goydos, J Hackell, J Mezzatesta, C Dekker, E A Mortimer.   

Abstract

Little information is available regarding the level of immunity to Bordetella pertussis among adolescents. We measured serum antibodies in 156 healthy adolescents to the following pertussis antigens: pertussis toxin, filamentous hemagglutinin, and 69-kd outer membrane protein. In an attempt to identify intercurrent pertussis infections, we also obtained a total of 43 repeated samples during the following 5 years. Using a 50% or greater rise in IgG enzyme-linked immunosorbent assay titers to define seroconversion, we found an annual incidence of 6.1%; by alternative definitions of seropositivity, the predicted annual incidence of infection ranged from 1.2% to 8.2%. These data suggest that infection with B pertussis is common in the adolescent population.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8488807     DOI: 10.1001/archpedi.1993.02160290081031

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  15 in total

1.  Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis.

Authors:  H E de Melker; F G Versteegh; M A Conyn-Van Spaendonck; L H Elvers; G A Berbers; A van Der Zee; J F Schellekens
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Pertussis immunization for adolescents: What are we waiting for?

Authors:  S A Halperin
Journal:  Can J Infect Dis       Date:  2001-03

3.  A comparison of pertussis rates in the Northwest Territories: Pre- and postacellular pertussis vaccine introduction in children and adolescents.

Authors:  Kami Kandola; Amy Lea; Wanda White; Maria Santos
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-09       Impact factor: 2.471

4.  Pertussis immunization for adolescents: What are we waiting for?

Authors:  S A Halperin
Journal:  Paediatr Child Health       Date:  2001-04       Impact factor: 2.253

5.  Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France.

Authors:  E Grimprel; P Bégué; I Anjak; E Njamkepo; P François; N Guiso
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

Review 6.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 7.  Which strategy for pertussis vaccination today?

Authors:  Dorota Z Girard
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 8.  Acellular pertussis vaccine safety and efficacy in children, adolescents and adults.

Authors:  Janet R Casey; Michael E Pichichero
Journal:  Drugs       Date:  2005       Impact factor: 9.546

9.  Geographic analysis of pertussis infection in an urban area: a tool for health services planning.

Authors:  C Siegel; A Davidson; K Kafadar; J M Norris; J Todd; J Steiner
Journal:  Am J Public Health       Date:  1997-12       Impact factor: 9.308

Review 10.  A cellular pertussis vaccine (Infanrix-DTPa; SB-3). A review of its immunogenicity, protective efficacy and tolerability in the prevention of Bordetella pertussis infection.

Authors:  S S Patel; A J Wagstaff
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.